#CartilageRegeneration #Osteoarthritis #ArthritisResearch #StanfordMedicine #JointHealth #KneeHealth #RegenerativeMedicine #HealthyAging #15PGDH #Chondrocytes #ACLInjury #JointReplacement #MedicalResearch #PreclinicalResearch #ScienceNew
Regentis Biomaterials' GelrinC hydrogel implant showed ~100% greater KOOS improvement vs. microfracture in Phase II trials. A U.S. pivotal trial targets completion by end of 2026, targeting 470,000 annual knee cartilage cases with no current off-the-shelf fix. #Orthopedics #RegenerativeMedicine
